These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26105374)

  • 21. Nested Case-Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia.
    Liu M; Wang RB; Xing JH; Tang YX
    Int J Gen Med; 2021; 14():2313-2320. PubMed ID: 34113161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A trio of risk factors for the onset of preeclampsia in the second and early third trimesters.
    Ohkuchi A; Hirashima C; Takahashi K; Shirasuna K; Suzuki H; Ariga H; Kobayashi M; Hirose N; Matsubara S; Suzuki M
    Pregnancy Hypertens; 2014 Jul; 4(3):224-30. PubMed ID: 26104610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model for Early Prediction of Preeclampsia: A Nested Case Controlled Study in Indian Women.
    Yadav S; Khandpur S; Yadav YS; Goel MM; Singh U; Natu SM; Negi MPS; Sharma LK; Tiwari S
    J Obstet Gynaecol India; 2022 Aug; 72(4):299-306. PubMed ID: 35923506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers.
    Garrido-Giménez C; Cruz-Lemini M; Álvarez FV; Nan MN; Carretero F; Fernández-Oliva A; Mora J; Sánchez-García O; García-Osuna Á; Alijotas-Reig J; Llurba E; On Behalf Of The EuroPE Working Group
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
    Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
    Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PP178. Antenatal sFlt1 and PlGF levels at 20-28weeks of gestation for prediction of the occurrence of preeclampsia: A preliminary report.
    Jantarasaengaram S; Tansatit T; Samkhoompim N
    Pregnancy Hypertens; 2012 Jul; 2(3):337. PubMed ID: 26105499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia.
    Miyatake R; Fujii T; Kumasawa K; Ichinose M; Toshimitsu M; Sayama S; Seyama T; Iriyama T; Nagamatsu T; Osuga Y
    Case Rep Obstet Gynecol; 2023; 2023():7352947. PubMed ID: 37766910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PP121. Expression of PlGF, sFlt, MTF-1, HO-1 and HIF-1 alpha mRNAs in preeclampsia placenta and effect of preeclampsia sera on their expression of choriocarcinoma cells.
    Maebayashi A; Yamamoto T; Azuma H; Kato E; Kuno S; Murase T; Chishima F
    Pregnancy Hypertens; 2012 Jul; 2(3):304-5. PubMed ID: 26105443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sFlt-1/PlGF Ratio at 12, 24, and 32 Weeks Gestation in Twin Pregnancies as a Predictor of Late Preterm Birth and Perinatal Event Secondary to Prematurity.
    Satorres-Pérez E; Martínez-Varea A; Novillo-Del Álamo B; Morales-Roselló J; Diago-Almela V
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731228
    [No Abstract]   [Full Text] [Related]  

  • 30. OS061. Placental growth factor reduces blood pressure and proteinuria in experimental preeclampsia.
    Makris A; Yeung K; Farrell P; Heffernan S; Thompson J; Xu B; Woolcock J; Ogle R; Thadhani R; Karumanchi A; Hennessy A
    Pregnancy Hypertens; 2012 Jul; 2(3):210. PubMed ID: 26105275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MATERNAL SERUM ANGIOGENIC FACTORS AS AN AIDING TOOL FOR SCREENING WOMEN WITH SUSPECTED PREECLAMPSIA NEAR DELIVERY - INITIAL DATA AND AN ESTIMATED COST-BENEFIT].
    Katz U; Maymon R; Tsviban A; Sharabi-Nov A; Abu Hamid R; Meiri H; Wiener Y
    Harefuah; 2022 Nov; 161(11):673-681. PubMed ID: 36578238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates.
    Witwicki J; Chaberek K; Szymecka-Samaha N; Krysiak A; Pietruski P; Kosińska-Kaczyńska K
    Children (Basel); 2021 Aug; 8(8):. PubMed ID: 34438609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating EGFL7 distinguishes between IUGR and PE: an observational case-control study.
    Massimiani M; Salvi S; Tiralongo GM; Moresi S; Stuhlmann H; Valensise H; Lanzone A; Campagnolo L
    Sci Rep; 2021 Sep; 11(1):17919. PubMed ID: 34504270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial.
    Ricart M; Bonacina E; Garcia-Manau P; López M; Caamiña S; Vives À; Lopez-Quesada E; Maroto A; de Mingo L; Pintado E; Ferrer-Costa R; Martín L; Rodriguez-Zurita A; Garcia E; Pallarols M; Pratcorona L; Teixidor M; Orizales-Lago C; Ocaña V; Del Barco E; Carreras E; Suy A; Mendoza M
    Acta Obstet Gynecol Scand; 2024 Nov; 103(11):2273-2280. PubMed ID: 39171611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of the sFlt-1/PlGF Ratio in Certain Cohorts - What Needs to be Considered?
    Graupner O; Verlohren S; Groten T; Schlembach D; Stepan H; Kuschel B; Karge A; Pecks U
    Geburtshilfe Frauenheilkd; 2024 Jul; 84(7):629-634. PubMed ID: 38993800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PP116. Circulating PlGF can help predict preeclampsia and adverse outcome in patients with suspected preeclampsia or fetal growth restriction.
    Sibiude J; Dionne MD; Guibourdenche J; Le Ray C; Anselem O; Serreau R; Goffinet F; Tsatsaris V
    Pregnancy Hypertens; 2012 Jul; 2(3):302-3. PubMed ID: 26105438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. sFlt-1 and IP-10 in women with early-onset preeclampsia.
    De Oliveira L; Câmara NO; Peraçoli JC; Peraçoli MT; Moron AF; Sass N
    Pregnancy Hypertens; 2011 Apr; 1(2):129-31. PubMed ID: 26104492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of Cerebroplacental Ratio in IUGR Fetuses from Pregnancy with Preeclampsia in Prediction the Risk for Perinatal Complications.
    Novac MV; Moldoveanu A; Tudorache Ş; Oprescu ND; Miescu M; Siminel MA; Vrabie S; Novac MB; Iliescu DG
    Curr Health Sci J; 2017; 43(3):231-235. PubMed ID: 30595881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PP006. The comparison of serum VEGF and sFlt-1 on preeclampsia and eclampsia pregnant woman before and after delivery at Ulin Hospital, Banjarmasin, Indonesia.
    Akbar A; Abimanyu B; Dachlan EG; Abadi A
    Pregnancy Hypertens; 2012 Jul; 2(3):243. PubMed ID: 26105329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PP067. Third trimester prediction of late PE.
    Meler E; Murillo E; Rodriguez I; Serra B
    Pregnancy Hypertens; 2013 Apr; 3(2):91. PubMed ID: 26105922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.